Elisabeth Crönert-Bendell
Corporate Officer/Principal presso RHYTHM PHARMACEUTICALS, INC.
Profilo
Elisabeth Crönert-Bendell is currently the Senior Vice President & Head-Strategy at Rhythm Pharmaceuticals, Inc. She previously worked as a Senior Vice President at Sanofi and as the Head-Neuroscience Business Franchise at Kyowa Kirin International Plc.
Dr. Crönert-Bendell holds an MBA from INSEAD.
Posizioni attive di Elisabeth Crönert-Bendell
| Società | Posizione | Inizio |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2021 |
Precedenti posizioni note di Elisabeth Crönert-Bendell
| Società | Posizione | Fine |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Corporate Officer/Principal | - |
Formazione di Elisabeth Crönert-Bendell
| INSEAD | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| SANOFI | Health Technology |
| Aziende private | 1 |
|---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Elisabeth Crönert-Bendell
